Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for COR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 -1.768B
March 31, 2026 3.979B
December 31, 2025 43.20M
September 30, 2025 -683.78M
June 30, 2025 215.48M
March 31, 2025 -491.74M
December 31, 2024 3.209B
September 30, 2024 -957.26M
June 30, 2024 -1.145B
March 31, 2024 323.17M
December 31, 2023 -551.67M
September 30, 2023 -407.01M
June 30, 2023 -81.87M
March 31, 2023 -769.45M
December 31, 2022 -963.94M
September 30, 2022 -673.46M
June 30, 2022 -694.73M
March 31, 2022 -278.16M
December 31, 2021 -106.42M
September 30, 2021 -444.61M
June 30, 2021 488.94M
March 31, 2021 2.453B
December 31, 2020 -544.47M
September 30, 2020 -19.99M
June 30, 2020 -73.46M
Date Value
March 31, 2020 -288.10M
December 31, 2019 -222.06M
September 30, 2019 -219.39M
June 30, 2019 -358.25M
March 31, 2019 -205.16M
December 31, 2018 -303.71M
September 30, 2018 -476.52M
June 30, 2018 -435.27M
March 31, 2018 -65.72M
December 31, 2017 734.63M
September 30, 2017 -165.33M
June 30, 2017 -711.17M
March 31, 2017 -72.82M
December 31, 2016 -363.49M
September 30, 2016 -331.79M
June 30, 2016 -703.52M
March 31, 2016 768.86M
December 31, 2015 831.52M
September 30, 2015 -1.363B
June 30, 2015 -848.19M
March 31, 2015 1.909B
December 31, 2014 -329.56M
September 30, 2014 -219.06M
June 30, 2014 236.36M
March 31, 2014 -707.10M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Cardinal Health, Inc. -487.00M
McKesson Corp. 394.00M
CVS Health Corp. -2.693B
Henry Schein, Inc. -158.00M
Accendra Health, Inc. -271.98M